US Patent Issued to Sarepta Therapeutics, Massachusetts Institute of Technology on July 29 for "Chimeric peptides for antisense delivery" (Massachusetts Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,261, issued on July 29, was assigned to Sarepta Therapeutics Inc. (Cambridge, Mass.) and Massachusetts Institute of Technology (Cambridge, Mass.).

"Chimeric peptides for antisense delivery" was invented by Bradley L. Pentelute (Cambridge, Mass.), Colin M. Fadzen (Cambridge, Mass.), Rebecca L. Holden (Cambridge, Mass.), Justin M. Wolfe (Cambridge, Mass.), Zi-Ning Choo (Cambridge, Mass.), Monica Yao (Cambridge, Mass.) and Gunnar J. Hanson (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are oligonucleotides, chimeric peptides, and peptide-oligonucleotide-conjugates, the chimeric peptides and peptide-oligonucleotide-conj...